Isomorphic Labs Limited

Royaume‑Uni

Retour au propriétaire

1-59 de 59 pour Isomorphic Labs Limited Trier par
Recheche Texte
Affiner par
Type PI
        Marque 38
        Brevet 21
Juridiction
        International 25
        États-Unis 20
        Canada 13
        Europe 1
Date
2026 août (MACJ) 1
2026 juin 5
2026 mai 6
2026 (AACJ) 19
2025 28
Voir plus
Classe IPC
G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire 12
G16B 40/20 - Analyse de données supervisée 9
G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie 9
G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques 5
G16B 15/20 - Repliement de protéines ou de domaines 4
Voir plus
Classe NICE
42 - Services scientifiques, technologiques et industriels, recherche et conception 29
09 - Appareils et instruments scientifiques et électriques 28
05 - Produits pharmaceutiques, vétérinaires et hygièniques 20
Statut
En Instance 25
Enregistré / En vigueur 34

1.

Isomorphic Labs Drug Design Engine

      
Numéro d'application 1932118
Statut Enregistrée
Date de dépôt 2026-07-09
Date d'enregistrement 2026-07-09
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SaaS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PaaS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

2.

IsoDDE

      
Numéro d'application 1923950
Statut Enregistrée
Date de dépôt 2026-05-15
Date d'enregistrement 2026-05-15
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

3.

PREDICTING JOINT THREE-DIMENSIONAL (3D) STRUCTURES OF PROTEINS AND LIGANDS BY COFOLDING

      
Numéro d'application 19537748
Statut En instance
Date de dépôt 2026-02-12
Date de la première publication 2026-06-25
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Inventeur(s)
  • Jaderberg, Maxwell Elliot
  • Hung, Chia-Chun
  • Bapst, Victor Constant
  • Dunger, Jack Tavis
  • Reiman, David
  • Wu, Zachary

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a predicted joint 3D structure of a protein and one or more ligands. In one aspect, a method comprises: obtaining a network input that characterizes the protein and the one or more ligands; processing the network input using an embedding neural network to generate a protein-ligand embedding of the protein and the one or more ligands; and generating, using a generative model and while the generative model is conditioned on the protein-ligand embedding, the predicted joint three-dimensional (3D) structure of the protein and the one or more ligands.

Classes IPC  ?

  • G06N 3/084 - Rétropropagation, p. ex. suivant l’algorithme du gradient

4.

MOLECULAR PROPERTY PREDICTION USING MOLECULE PROTONATION STATES

      
Numéro d'application EP2025087169
Numéro de publication 2026/131690
Statut Délivré - en vigueur
Date de dépôt 2025-12-15
Date de publication 2026-06-25
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Mouvet, François Louis
  • Ross, Gregory Antonio

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a prediction characterizing a molecule. According to one aspect, there is provided a method comprising: receiving data identifying a molecule; generating data defining a protonation state graph for the molecule, wherein: each node in the graph represents a respective protonation state of the molecule; and each edge in the graph corresponds to a respective protonation site on the molecule and connects a respective pair of nodes in the graph that represent a corresponding pair of possible protonation states of the molecule that differ only in a protonation state of the corresponding protonation site on the molecule; and each edge in the graph is associated with a predicted micro pKa value of the corresponding protonation site; and processing the data defining the graph for the molecule to generate a prediction characterizing the molecule.

Classes IPC  ?

  • G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie
  • G16C 20/80 - Visualisation de données

5.

AUTOMATED LIGAND DESIGN

      
Numéro d'application 19294856
Statut En instance
Date de dépôt 2025-08-08
Date de la première publication 2026-06-11
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Inventeur(s)
  • Grattarola, Daniele
  • Feinauer, Christoph Johann
  • Jaderberg, Maxwell Elliot

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for iteratively designing a ligand for binding to a protein. In one aspect, a method comprises, at each of a plurality of design iterations, performing operations comprising: generating, by a controller, a current set of ligand design criteria that define desired characteristics of the ligand; generating, using a generative model and while the generative model is conditioned on: (i) protein data characterizing the protein, and (ii) the ligand design criteria generated by the controller, data defining a set of candidate ligands that are predicted to bind to the protein; determining, for each of a plurality of the candidate ligands, a respective quality score for the candidate ligand based on properties of the candidate ligand; and updating the controller using the respective quality scores for the candidate ligands.

Classes IPC  ?

  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 40/30 - Analyse de données non supervisée
  • G16B 45/00 - TIC spécialement adaptées à la visualisation de données liées à la bio-informatique, p. ex. affichage de cartes ou de réseaux
  • G16B 50/30 - Entreposage de donnéesArchitectures informatiques

6.

SCORING PREDICTED THREE-DIMENSIONAL (3D) STRUCTURES OF MOLECULAR SYSTEMS

      
Numéro d'application EP2025083548
Numéro de publication 2026/114715
Statut Délivré - en vigueur
Date de dépôt 2025-11-19
Date de publication 2026-06-04
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Tong, Eu Gen Catherine
  • Hung, Chia-Chun

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a quality score for a 3D structure of a molecular system In one aspect, a method comprises: receiving data identifying one or more molecules included in a molecular system; processing a model input that identifies the one or more molecules included in the molecular system using a generative machine learning model to generate, as model outputs of the generative machine learning model, a plurality of predicted 3D structures of the molecular system; generating, for each of the plurality of predicted 3D structures of the molecular system, a quality score; and outputting the plurality of predicted 3D structures of the molecular system and the quality scores for the plurality of predicted 3D structures of the molecular system.

Classes IPC  ?

  • G16B 15/20 - Repliement de protéines ou de domaines
  • G06N 3/0475 - Réseaux génératifs
  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 40/20 - Analyse de données supervisée
  • G16C 20/50 - Conception moléculaire, p. ex. de médicaments
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie

7.

ISOMORPHIC

      
Numéro d'application 247993600
Statut En instance
Date de dépôt 2026-05-20
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Pharmaceutical preparations. (2) Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. (1) Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

8.

ISODDE

      
Numéro de série 79452592
Statut En instance
Date de dépôt 2026-05-15
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

9.

TRAINING GENERATIVE MACHINE LEARNING MODELS ON MOLECULAR DYNAMICS SIMULATION DATA

      
Numéro d'application EP2025080557
Numéro de publication 2026/098969
Statut Délivré - en vigueur
Date de dépôt 2025-10-22
Date de publication 2026-05-15
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Wirnsberger, Peter
  • Hutchinson, Michael John
  • Schaarschmidt, Kevin Michael
  • Tsekouras, Luke George

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for training a generative machine learning model In one aspect, a method comprises: obtaining a set of training examples for training a generative machine learning model to perform a structure prediction task; augmenting the set of training examples to include a plurality of new training examples, comprising, for each training example in the set of training examples: performing a molecular dynamics simulation of a molecular system, starting from a conformation of the molecular system that is specified by the training example, to generate a trajectory of new conformations adopted by the molecular system over a duration of time; generating one or more new training examples corresponding to the molecular system; and training the generative machine learning model to perform the structure prediction task on the augmented set of training examples.

Classes IPC  ?

  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie
  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire

10.

PHYSICS-BASED GUIDANCE FOR MOLECULAR STRUCTURE PREDICTION USING GENERATIVE DIFFUSION MODELS

      
Numéro d'application EP2025081712
Numéro de publication 2026/099134
Statut Délivré - en vigueur
Date de dépôt 2025-11-03
Date de publication 2026-05-15
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Reddy, Siddharth Gajjala
  • Dunger, Jack Tavis
  • Hung, Chia-Chun

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for determining a predicted 3D structure of a molecular system In one aspect, a method comprises using a generative diffusion model to generate the predicted 3D structure of the molecular system by denoising 3D structure data for the molecular system over a sequence of denoising iterations, comprising, at each of a plurality of denoising iterations: processing current structure data for the molecular system using a physics scoring model to generate a physics score that characterizes a degree to which the current structure data satisfies one or more physical constraints on the 3D structure of the molecular system; and generating a respective physics adjustment to the spatial position for each of the plurality of atoms based on the physics score.

Classes IPC  ?

  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16C 20/50 - Conception moléculaire, p. ex. de médicaments
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie

11.

IsoDDE

      
Numéro d'application 248435500
Statut En instance
Date de dépôt 2026-05-15
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. (1) Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

12.

SYNTHETIC DATA GENERATION USING MATCHED MOLECULAR PAIRS

      
Numéro d'application EP2025081180
Numéro de publication 2026/093340
Statut Délivré - en vigueur
Date de dépôt 2025-10-28
Date de publication 2026-05-07
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Richards, Simon James
  • Rose, Harry

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating synthetic training examples for training a machine learning model. In one aspect, a method comprises: processing the data identifying a collection of molecules to identify a plurality of matched molecular pairs; processing the plurality of matched molecular pairs to generate data defining a set of transformation functions, wherein each transformation function is defined by at least: (i) a first molecular fragment; (ii) a second molecular fragment; (iii) an inclusion criterion defining a class of molecules; and (iv) a predicted change in the molecular property value resulting from replacing the first molecular fragment by the second molecular fragment in a molecule that satisfies the inclusion criterion; generating a plurality of synthetic training examples for training a machine learning model using the set of transformation functions.

Classes IPC  ?

  • G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie

13.

UNIFIED STRUCTURE MODEL FOR MOLECULE PROPERTY AND STRUCTURE PREDICTION

      
Numéro d'application 19316998
Statut En instance
Date de dépôt 2025-09-02
Date de la première publication 2026-03-12
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Inventeur(s)
  • Hung, Chia-Chun
  • Jaderberg, Maxwell Elliot
  • Bambrick, Joshua Patrick
  • Briody, Joss William
  • Schaarschmidt, Kevin Michael
  • Rampášek, Ladislav
  • Feinauer, Christoph Johann
  • Ayoola, Thomas
  • Osokin, Anton
  • Rózemberczki, Benedek Andras
  • Malinin, Andrey
  • Ashukha, Arsenii
  • Grattarola, Daniele
  • Abramson, Joshua Simon
  • Dunger, Jack Tavis
  • Evans, Richard Andrew
  • Bapst, Victor Constant
  • Czarnecki, Wojciech
  • Reiman, David
  • Wu, Zachary

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating predictions characterizing one or more molecules. In one aspect, a method comprises obtaining molecule data characterizing a molecule; processing a network input comprising the molecule data using an embedding neural network to generate a molecule embedding representing the molecule; and processing the molecule embedding representing the molecule using a prediction machine learning model to generate an output prediction characterizing the molecule, wherein the embedding neural network has been jointly trained along with a plurality of prediction neural networks that are each configured to perform a respective prediction task by operations comprising: receiving an input molecule embedding that represents one or more molecules and that is generated by the embedding neural network; and processing the input molecule embedding to generate a corresponding prediction characterizing the one or more molecules.

Classes IPC  ?

  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 15/20 - Repliement de protéines ou de domaines
  • G16B 40/20 - Analyse de données supervisée

14.

UNIFIED STRUCTURE MODEL FOR MOLECULE PROPERTY AND STRUCTURE PREDICTION

      
Numéro d'application EP2025075187
Numéro de publication 2026/052718
Statut Délivré - en vigueur
Date de dépôt 2025-09-04
Date de publication 2026-03-12
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Hung, Chia-Chun
  • Jaderberg, Maxwell Elliot
  • Bambrick, Joshua Patrick
  • Briody, Joss William
  • Schaarschmidt, Kevin Michael
  • Rampášek, Ladislav
  • Feinauer, Christoph Johann
  • Ayoola, Thomas
  • Osokin, Anton
  • Rózemberczki, Benedek Andras
  • Malinin, Andrey
  • Ashukha, Arsenii
  • Grattarola, Daniele
  • Abramson, Joshua Simon
  • Dunger, Jack Tavis
  • Evans, Richard Andrew
  • Bapst, Victor Constant
  • Czarnecki, Wojciech
  • Reiman, David
  • Wu, Zachary

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating predictions characterizing one or more molecules. In one aspect, a method comprises obtaining molecule data characterizing a molecule; processing a network input comprising the molecule data using an embedding neural network to generate a molecule embedding representing the molecule; and processing the molecule embedding representing the molecule using a prediction machine learning model to generate an output prediction characterizing the molecule, wherein the embedding neural network has been jointly trained along with a plurality of prediction neural networks that are each configured to perform a respective prediction task by operations comprising: receiving an input molecule embedding that represents one or more molecules and that is generated by the embedding neural network; and processing the input molecule embedding to generate a corresponding prediction characterizing the one or more molecules.

Classes IPC  ?

15.

ISOMORPHIC

      
Numéro d'application 1905362
Statut Enregistrée
Date de dépôt 2025-12-10
Date d'enregistrement 2025-12-10
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations. Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

16.

SOLVE ALL DISEASE

      
Numéro d'application 1904298
Statut Enregistrée
Date de dépôt 2025-12-10
Date d'enregistrement 2025-12-10
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations. Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

17.

AUTOMATED LIGAND DESIGN

      
Numéro d'application EP2025072887
Numéro de publication 2026/037746
Statut Délivré - en vigueur
Date de dépôt 2025-08-08
Date de publication 2026-02-19
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Grattarola, Daniele
  • Jaderberg, Maxwell Elliot
  • Feinauer, Christoph Johann

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for iteratively designing a ligand for binding to a protein. In one aspect, a method comprises, at each of a plurality of design iterations, performing operations comprising: generating, by a controller, a current set of ligand design criteria that define desired characteristics of the ligand; generating, using a generative model and while the generative model is conditioned on: (i) protein data characterizing the protein, and (ii) the ligand design criteria generated by the controller, data defining a set of candidate ligands that are predicted to bind to the protein; determining, for each of a plurality of the candidate ligands, a respective quality score for the candidate ligand based on properties of the candidate ligand; and updating the controller using the respective quality scores for the candidate ligands.

Classes IPC  ?

  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G06N 3/045 - Combinaisons de réseaux
  • G16B 40/20 - Analyse de données supervisée
  • G16C 20/50 - Conception moléculaire, p. ex. de médicaments

18.

PREDICTING MOLECULE SYNTHESIZABILITY USING MACHINE LEARNING

      
Numéro d'application 19282591
Statut En instance
Date de dépôt 2025-07-28
Date de la première publication 2026-01-29
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Inventeur(s)
  • Tigas, Panagiotis
  • Smith, Raymond Wensley

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for predicting synthesis complexity. In one aspect, a method comprises: receiving data characterizing a molecule; processing a model input that comprises the data characterizing the molecule, using a retrosynthesis featurization machine learning model and in accordance with values of a set of retrosynthesis featurization machine learning model parameters, to generate a feature array comprising a plurality of features of a retrosynthesis tree for the molecule; and processing a model input that comprises the feature array comprising the plurality of features of the retrosynthesis tree for the molecule, using a synthesizability prediction machine learning model and in accordance with values of a set of synthesizability prediction machine learning model parameters, to generate a synthesizability score that characterizes a synthesis complexity of the molecule.

Classes IPC  ?

  • G16C 20/10 - Analyse ou conception des réactions, des synthèses ou des procédés chimiques
  • G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
  • G16C 20/40 - Recherche de structures chimiques ou de données physicochimiques
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie

19.

Isomorphic Labs

      
Numéro d'application 1895081
Statut Enregistrée
Date de dépôt 2025-09-22
Date d'enregistrement 2025-09-22
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations. Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service [saas] services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

20.

MACHINE LEARNING MODELS FOR HIERARCHICAL MOLECULAR PROPERTY PREDICTION

      
Numéro d'application 19247583
Statut En instance
Date de dépôt 2025-06-24
Date de la première publication 2025-12-25
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Inventeur(s)
  • Kurin, Vitaly
  • Rose, Harry
  • Tigas, Panagiotis
  • Smith, Raymond Wensley
  • Richards, Simon James
  • Evans, Sian Elizabeth

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for predicting properties of molecules based on the structure and composition of the molecules. In one aspect, a method comprises receiving molecule data characterizing a molecule and processing a model input based on the molecule data characterizing the molecule using a property prediction machine learning model comprising an ordered sequence of processing layers to generate, for each of a set of molecule properties, a respective value for the molecule property wherein: each processing layer is associated with a respective proper subset of the set of molecule properties; and each processing layer after the first in the sequence generates predicted molecule property values based on: (i) the model input to the property prediction machine learning model, and (ii) predicted molecule property values generated by one or more preceding processing layers in the sequence of processing layers.

Classes IPC  ?

  • G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
  • G06N 3/042 - Réseaux neuronaux fondés sur la connaissanceReprésentations logiques de réseaux neuronaux
  • G06N 3/08 - Méthodes d'apprentissage
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie

21.

SOFTWARE PLATFORM FOR DRUG DISCOVERY

      
Numéro d'application 19233030
Statut En instance
Date de dépôt 2025-06-10
Date de la première publication 2025-12-25
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Inventeur(s)
  • Cheung, Jonathan Wai-Chuen
  • Murtagh, Robert James
  • Kay, William Thomas
  • Shafi, Amber

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for dynamically updating the display of the user device as a user interacts with the graphical user interface. In one aspect, a method comprises, at each of a plurality of update iterations: initiating the update iteration in response to determining that a user of the user device has interacted with the graphical user interface to modify the chemical structure of a molecule being presented on the display of the user device; automatically determining a respective updated value, for the updated molecule, of each molecule property in the set of molecule properties using the set of updated molecule data; and updating the display of the user device to present: (i) a graphical representation of the updated molecule, and (ii) the respective updated value, for the updated molecule, of each molecule property in the set of molecule properties.

Classes IPC  ?

  • G06F 30/20 - Optimisation, vérification ou simulation de l’objet conçu
  • G16H 70/40 - TIC spécialement adaptées au maniement ou au traitement de références médicales concernant des médicaments, p. ex. leurs effets secondaires ou leur usage prévu

22.

SOLVE ALL DISEASE

      
Numéro de série 79444538
Statut En instance
Date de dépôt 2025-12-10
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations. Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

23.

ISOMORPHIC

      
Numéro de série 79444986
Statut En instance
Date de dépôt 2025-12-10
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations. Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services.

24.

MACHINE LEARNING METHODS FOR PREDICTING PROPERTIES OF PROTEINS AND LIGANDS

      
Numéro d'application 19213674
Statut En instance
Date de dépôt 2025-05-20
Date de la première publication 2025-11-27
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Inventeur(s)
  • Jaderberg, Maxwell Elliot
  • Czarnecki, Wojciech
  • Ashukha, Arsenii
  • Rózemberczki, Benedek Andras
  • Ayoola, Thomas
  • Briody, Joss William
  • Malinin, Andrey
  • Kirkpatrick, James

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a predicted property score of a protein and a ligand. In one aspect, a method comprises: obtaining a network input that characterizes a protein and a ligand; processing the network input characterizing the protein and the ligand using an embedding neural network to generate a protein-ligand embedding representing the protein and the ligand, wherein the embedding neural network has been jointly trained with a generative model that is configured to: receive an input protein-ligand embedding; and generate, while conditioned on the input protein-ligand embedding, a predicted joint three-dimensional (3D) structure of an input protein and an input ligand represented by the input protein-ligand embedding; and generating a property score that defines a predicted property of the protein and the ligand using the protein-ligand embedding.

Classes IPC  ?

  • G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
  • G06N 3/084 - Rétropropagation, p. ex. suivant l’algorithme du gradient
  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire

25.

ISOLABS

      
Numéro d'application 1886040
Statut Enregistrée
Date de dépôt 2025-09-16
Date d'enregistrement 2025-09-16
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine earning, deep learning, and reinforcement learning; development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

26.

DESIGNING LIGANDS USING GENERATIVE MODELS

      
Numéro d'application EP2025058453
Numéro de publication 2025/202392
Statut Délivré - en vigueur
Date de dépôt 2025-03-27
Date de publication 2025-10-02
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Jaderberg, Maxwell Elliot
  • Feinauer, Christoph Johann
  • Grattarola, Daniele
  • Bartunov, Sergey
  • Vignac, Clément Arthur

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for computationally designing a ligand for binding to a target molecule. In one aspect, a method comprises: obtaining target molecule data characterizing at least a portion of a target molecule; processing a network input comprising the target molecule data using an embedding neural network to generate latent conditioning data representing the target molecule; generating, using a generative model and while the generative model is conditioned on the latent conditioning data representing the target molecule, predicted ligand data defining a predicted ligand that is predicted to bind to the target molecule; and providing the predicted ligand data defining the predicted ligand.

Classes IPC  ?

  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 40/20 - Analyse de données supervisée
  • G16C 20/50 - Conception moléculaire, p. ex. de médicaments
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie

27.

IL ISOMORPHIC LABS

      
Numéro d'application 244739400
Statut En instance
Date de dépôt 2025-09-22
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Pharmaceutical preparations. (2) Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. (1) Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service [saas] services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

28.

ISOMORPHIC LABS

      
Numéro de série 79440662
Statut En instance
Date de dépôt 2025-09-22
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations. Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service [saas] services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

29.

ISOLABS

      
Numéro d'application 243697100
Statut En instance
Date de dépôt 2025-09-16
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. (1) Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine earning, deep learning, and reinforcement learning; development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

30.

ISOMORPHIC LABORATORIES

      
Numéro d'application 1873634
Statut Enregistrée
Date de dépôt 2025-08-01
Date d'enregistrement 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

31.

ISOLABS

      
Numéro d'application 1873636
Statut Enregistrée
Date de dépôt 2025-08-01
Date d'enregistrement 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

32.

Miscellaneous Design

      
Numéro d'application 1873637
Statut Enregistrée
Date de dépôt 2025-08-01
Date d'enregistrement 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations. Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus. Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software.

33.

ISOMORPHIC LABS

      
Numéro d'application 1873756
Statut Enregistrée
Date de dépôt 2025-08-01
Date d'enregistrement 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

34.

ISOMORPHIC LABORATORIES

      
Numéro d'application 242252900
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations.

35.

ISOMORPHIC LABS

      
Numéro d'application 242252800
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations.

36.

IL

      
Numéro d'application 242253200
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Pharmaceutical preparations. (2) Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus. (1) Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software.

37.

Miscellaneous Design

      
Numéro de série 79431751
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical preparations for the treatment of systemic inflammatory and immunological conditions; pharmaceutical preparations for the treatment of oncological and hematological diseases; pharmaceutical preparations for the treatment of metabolic and endocrine disorders; pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for the treatment of infectious diseases Scientific and technological services, namely, research and design in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; design and development of computer hardware and software

38.

ISOLABS

      
Numéro d'application 242253100
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations.

39.

ISOMORPHIC LABS

      
Numéro de série 79431805
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of systemic inflammatory and immunological conditions; pharmaceutical preparations for the treatment of oncological and hematological diseases; pharmaceutical preparations for the treatment of metabolic and endocrine disorders; pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for the treatment of infectious diseases

40.

ISOMORPHIC LABORATORIES

      
Numéro de série 79431748
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of systemic inflammatory and immunological conditions; pharmaceutical preparations for the treatment of oncological and hematological diseases; pharmaceutical preparations for the treatment of metabolic and endocrine disorders; pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for the treatment of infectious diseases

41.

ISOLABS

      
Numéro de série 79431750
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of systemic inflammatory and immunological conditions; pharmaceutical preparations for the treatment of oncological and hematological diseases; pharmaceutical preparations for the treatment of metabolic and endocrine disorders; pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for the treatment of infectious diseases

42.

GENERATING RETROSYNTHESIS TREES USING REACTION MODELING NEURAL NETWORKS

      
Numéro d'application EP2024084567
Numéro de publication 2025/140829
Statut Délivré - en vigueur
Date de dépôt 2024-12-03
Date de publication 2025-07-03
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Smith, Raymond Wensley
  • Talbot, Eric Philippe Andre
  • Richards, Simon James

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a retrosynthesis tree for a target molecule In one aspect, there is provided a method comprising: selecting a leaf node that is included in one or more retrosynthesis trees in a collection of retrosynthesis trees; processing data defining the respective molecule represented by the selected leaf node, using a reaction modeling neural network, to generate a score distribution over a set of chemical reactions that produce the respective molecule represented by the selected leaf node; selecting one or more chemical reactions from the set of chemical reactions using the score distribution over the set of chemical reactions; and generating one or more new retrosynthesis trees that each extend a respective retrosynthesis tree that includes the selected leaf node based on the one or more chemical reactions selected from the set of chemical reactions.

Classes IPC  ?

  • G16C 20/10 - Analyse ou conception des réactions, des synthèses ou des procédés chimiques

43.

GRAPH NEURAL NETWORKS FOR PREDICTING MICRO PKA

      
Numéro d'application EP2024083113
Numéro de publication 2025/131529
Statut Délivré - en vigueur
Date de dépôt 2024-11-21
Date de publication 2025-06-26
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s) Schaarschmidt, Kevin Michael

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for predicting micro pKa.

Classes IPC  ?

  • G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
  • G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie

44.

PREDICTING JOINT THREE-DIMENSIONAL (3D) STRUCTURES OF PROTEINS AND LIGANDS BY COFOLDING

      
Numéro de document 03302479
Statut En instance
Date de dépôt 2024-10-29
Date de disponibilité au public 2025-05-08
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Jaderberg, Maxwell Elliot
  • Hung, Chia-Chun
  • Bapst, Victor Constant
  • Dunger, Jack Tavis
  • Reiman, David
  • Wu, Zachary

Classes IPC  ?

  • G16B 15/20 - Repliement de protéines ou de domaines
  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 40/20 - Analyse de données supervisée

45.

RANKING CANDIDATE LIGANDS BY COMPETITIVE CO-FOLDING

      
Numéro d'application EP2024080476
Numéro de publication 2025/093502
Statut Délivré - en vigueur
Date de dépôt 2024-10-28
Date de publication 2025-05-08
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Czarnecki, Wojciech
  • Jaderberg, Maxwell Elliot
  • Sverrisson, Freyr

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a ranking of candidate ligands from a set of candidate ligands that is indicative of respective predicted binding affinities of each of the candidate ligands for a protein. In one aspect, a method comprises: generating respective co-folding data for each of a plurality of pairs of candidate ligands, comprising, for each pair of candidate ligands: processing data defining the pair of candidate ligands and the protein using a co-folding neural network to generate data defining a joint three-dimensional (3D) structure of the pair of candidate ligands and the protein; and generating the co-folding data for the pair of candidate ligands based on the joint 3D structure of the pair of candidate ligands and the protein; and processing the co-folding data to generate the ranking.

Classes IPC  ?

  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 40/20 - Analyse de données supervisée

46.

RANKING CANDIDATE LIGANDS BY COMPETITIVE CO-FOLDING

      
Numéro de document 03302035
Statut En instance
Date de dépôt 2024-10-28
Date de disponibilité au public 2025-05-08
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Czarnecki, Wojciech
  • Jaderberg, Maxwell Elliot
  • Sverrisson, Freyr

Classes IPC  ?

  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 40/20 - Analyse de données supervisée

47.

PREDICTING JOINT THREE-DIMENSIONAL (3D) STRUCTURES OF PROTEINS AND LIGANDS BY COFOLDING

      
Numéro d'application EP2024080580
Numéro de publication 2025/093548
Statut Délivré - en vigueur
Date de dépôt 2024-10-29
Date de publication 2025-05-08
Propriétaire ISOMORPHIC LABS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Jaderberg, Maxwell Elliot
  • Hung, Chia-Chun
  • Bapst, Victor Constant
  • Dunger, Jack Tavis
  • Reiman, David
  • Wu, Zachary

Abrégé

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a predicted joint 3D structure of a protein and one or more ligands. In one aspect, a method comprises: obtaining a network input that characterizes the protein and the one or more ligands; processing the network input using an embedding neural network to generate a protein - ligand embedding of the protein and the one or more ligands; and generating, using a generative model and while the generative model is conditioned on the protein - ligand embedding, the predicted joint three-dimensional (3D) structure of the protein and the one or more ligands.

Classes IPC  ?

  • G16B 15/20 - Repliement de protéines ou de domaines
  • G16B 15/30 - Ciblage de médicament à l’aide de données structurellesPrévision d’amarrage ou de liaison moléculaire
  • G16B 40/20 - Analyse de données supervisée

48.

ISONOVA

      
Numéro d'application 019032717
Statut Enregistrée
Date de dépôt 2024-05-27
Date d'enregistrement 2024-10-23
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Downloadable software for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering drugs, designing drug candidates, biologic product development, and pharmaceutical product development; downloadable computer software for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, machine learning methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies, for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer programs for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, machine learning methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies, for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, machine learning methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies, for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; downloadable computer software for conducting therapeutic product research and development; downloadable computer software for discovering, optimizing and developing drugs; downloadable computer software for designing and developing drug candidates. Software as a service (SAAS) services featuring software for protein structure prediction, drug discovery, drug candidate design, biological product development, and pharmaceutical product development; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, or reinforcement learning for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; platform as a service (PaaS) services featuring software for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; platform as a service (PaaS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, drug discovery, development of biologic materials, development of biologic products, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; providing online, non-downloadable computer software platforms for protein structure prediction, drug discovery, drug candidate design, biologic material development, , and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, or reinforcement learning for protein structure prediction, drug discovery, drug candidate design, biological produce development, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; scientific, pharmaceutical, biotech, medical, and artificial intelligence research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, biotech research, protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; product research and development; medical, pharmaceutical, biotech, and scientific research in the field of protein structure prediction, drug discovery, drug candidate design, biologic product development, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning, virtual reality, science, chemistry, medicinal chemistry, physics, biology, and digital biology, all for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, all for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of analytics and data mining, virtual reality, augmented reality, chemistry, medicinal chemistry, physics, biology, and digital biology, all for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer modelling services; technical or scientific services for the analysis of compositions of matter; technical consulting in the field of pharmaceutical studies; drug discovery, drug design, optimization and development services; research and development of therapeutic products; drug discovery, optimization and development services; therapeutic and diagnostic candidate design services.

49.

ISONOVA

      
Numéro de série 98510322
Statut Enregistrée
Date de dépôt 2024-04-19
Date d'enregistrement 2025-02-25
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Downloadable software for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering drugs, designing drug candidates, biologic product development, and pharmaceutical product development; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, machine learning methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies, for protein structure prediction, l drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; downloadable computer software for conducting therapeutic product research and development; downloadable computer software for discovering, optimizing and developing drugs; downloadable computer software for designing and developing drug candidates Software as a service (SAAS) services featuring software for protein structure prediction, drug discovery, drug candidate design, biological product development, and pharmaceutical product development; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, or reinforcement learning for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; platform as a service (PaaS) services featuring software for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; platform as a service (PaaS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, drug discovery, development of biologic materials, development of biologic products, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; providing online, non-downloadable computer software platforms for protein structure prediction, drug discovery, drug candidate design, biologic material development, , and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, or reinforcement learning for protein structure prediction, drug discovery, drug candidate design, biological produce development, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; scientific, pharmaceutical, biotech, medical, and artificial intelligence research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, biotech research, protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; product research and development; medical, pharmaceutical, biotech, and scientific research in the field of protein structure prediction, drug discovery, drug candidate design, biologic product development, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning, virtual reality, science, chemistry, medicinal chemistry, physics, biology, and digital biology, all for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, medicinal chemistry, physics, biology, and digital biology, all for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer modelling services; technical or scientific services for the analysis of compositions of matter; technical consulting in the field of pharmaceutical studies; drug discovery, drug design, optimization and development services; research and development of therapeutic products; drug discovery, optimization and development services; medical and scientific services in the field of pharmaceuticals, namely, therapeutic and diagnostic candidate design services

50.

ISOMORPHIC LABS

      
Numéro d'application 1683865
Statut Enregistrée
Date de dépôt 2022-02-21
Date d'enregistrement 2022-02-21
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning (in the opinion of the International Bureau these terms are too vague - Rule 13.2.b) of the Common Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

51.

Miscellaneous Design

      
Numéro d'application 1683863
Statut Enregistrée
Date de dépôt 2022-02-18
Date d'enregistrement 2022-02-18
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Software as a service (SaaS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning (in the opinion of the International Bureau these terms are too vague - Rule 13.2.b) of the Common Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

52.

ISOMORPHIC LABORATORIES

      
Numéro d'application 1681756
Statut Enregistrée
Date de dépôt 2022-02-18
Date d'enregistrement 2022-02-18
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine earning, deep learning, and reinforcement learning (in the opinion of the International Bureau these terms are too vague - Rule 13.2.b) of the Common Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

53.

ISOLABS

      
Numéro de série 97491421
Statut Enregistrée
Date de dépôt 2022-07-06
Date d'enregistrement 2025-05-06
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software applications for designing and developing artificial intelligence, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for software development in the fields of software for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development and testing of computing methods, computer software algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research and technological consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology, and scientific research; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services

54.

ISOMORPHIC LABS

      
Numéro d'application 220949400
Statut Enregistrée
Date de dépôt 2022-02-21
Date d'enregistrement 2025-05-23
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for designing and developing artificial intelligence technologies, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; computer software, computer programs and computer software algorithms for manipulating received and inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. (1) Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; pharmaceutical and medical research; scientific research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development in the field of pharmaceuticals and over-the-counter drugs; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, and development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services, namely developing computer models that represent biomolecular processes for use in the development of pharmaceutical drugs; scientific services for analyzing the properties of organic compounds; drug discovery services.

55.

ISOMORPHIC LABORATORIES

      
Numéro d'application 220825400
Statut Enregistrée
Date de dépôt 2022-02-18
Date d'enregistrement 2025-05-23
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for designing and developing artificial intelligence technologies, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; computer software, computer programs and computer software algorithms for manipulating received and inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. (1) Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; pharmaceutical and medical research; scientific research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development in the field of pharmaceuticals and over-the-counter drugs; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, and development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services, namely developing computer models that represent biomolecular processes for use in the development of pharmaceutical drugs; scientific services for analyzing the properties of organic compounds; drug discovery services.

56.

IL

      
Numéro d'application 220949000
Statut Enregistrée
Date de dépôt 2022-02-18
Date d'enregistrement 2025-05-02
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for designing and developing artificial intelligence technologies, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; computer software, computer programs and computer software algorithms for manipulating received and inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for developing software for others in the fields of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. (1) Software as a service (SaaS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development and testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; pharmaceutical and medical research; scientific research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development in the field of pharmaceuticals and over-the-counter drugs; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research and technical consulting, scientific research, and development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services, namely developing computer models that represent biomolecular processes for use in the development of pharmaceutical drugs; scientific services for analyzing the properties of organic compounds; drug discovery services.

57.

Miscellaneous Design

      
Numéro de série 97272458
Statut Enregistrée
Date de dépôt 2022-02-17
Date d'enregistrement 2025-05-06
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software applications for designing and developing artificial intelligence, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for software development in the fields of software for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development and testing of computing methods, computer software algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research and technological consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology, and scientific research; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services

58.

ISOMORPHIC LABS

      
Numéro de série 97170031
Statut Enregistrée
Date de dépôt 2021-12-13
Date d'enregistrement 2025-05-06
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine earning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services

59.

ISOMORPHIC LABORATORIES

      
Numéro de série 97170047
Statut Enregistrée
Date de dépôt 2021-12-13
Date d'enregistrement 2025-05-06
Propriétaire Isomorphic Labs Limited (Royaume‑Uni)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine earning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services